Invoxin-LB 625 Tablet
Manufacturer
Indmark Biotech Private Limited
Salt Composition
Amoxycillin (500mg) + Clavulanic Acid (125mg) + Lactobacillus (60Million spores)
Key Information
Short Description
Invoxin-LB 625 Tablet is a combination medicine used to treat various types of bacterial infections. It fights against microorganisms to prevent their growth and further spread of the infection.
Dosage Form
Tablet
Introduction
Invoxin-LB 625 Tablet is a prescription medicine. It is advised to take it as per the prescription. It can be taken with or without food but it must be taken at a fixed time to ensure better efficacy. Do not consume more than the recommended dose as this may have harmful effects on your body.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Invoxin-LB 625 Tablet may be taken with or without food but it is better to take it at a fixed time.
How it works
Invoxin-LB 625 Tablet is a combination of three medicines: Amoxycillin, Clavulanic Acid and Lactobacillus. Amoxycillin is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Amoxycillin against bacteria. This treats your infection but may upset your digestive system by killing healthy gut bacteria as well. Lactobacillus is added to restore the balance of healthy bacteria.
Quick Tips
You have been prescribed this combination medicine to treat bacterial infections even if they have developed resistance. Take it with food and plenty of fluids to avoid an upset stomach. Finish the prescribed course even if you start to feel better. Stopping it early may make the infection come back and harder to treat. Diarrhea may occur as a side effect. Taking probiotics along with Invoxin-LB 625 Tablet may help. Talk to your doctor if you notice bloody stools or develop abdominal cramps. Stop taking Invoxin-LB 625 Tablet and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it.
Related Medicines
Augpen LB 625 Tablet
Magniclav-LB 625 Tablet
Hoxaclav LB 500mg/125mg Tablet
Ralimox CL 500mg/125mg Tablet
Rion LB 500mg/125mg Tablet
Moxycad CV LB 500mg/125mg Tablet
Geclav-LB Tablet
Clamozen LB 500mg/125mg Tablet
Nuciclave LB Tablet 500mg/125mg
Aspiclav LB 500mg/125mg Tablet
Frequently asked questions
Are there any contraindications for using Invoxin-LB 625 Tablet?
Invoxin-LB 625 Tablet is contraindicated in patients with a history of hypersensitivity to penicillin or other penicillins, and those with a previous history of cholestatic jaundice/liver dysfunction associated with the medicine. It should not be administered in these cases.
What is the recommended dosage and timing for Invoxin-LB 625 Tablet?
Invoxin-LB 625 Tablet can be taken every 8 hours or every 12 hours, as prescribed by your doctor. It should be taken with food to help prevent gastrointestinal upset.
When is the best time to stop Invoxin-LB 625 Tablet?
Do not stop taking Invoxin-LB 625 Tablet before completing your entire course of treatment as prescribed by your doctor, even if you start feeling better. Skipping doses or stopping prematurely can reduce the effectiveness of the treatment and might contribute to bacterial resistance.
Can I take Invoxin-LB 625 Tablet if I am allergic to penicillin?
If you have a history of hypersensitivity to one type of penicillin, you may experience adverse reactions to ampicillin or certain cephalosporins. However, this is not always the case, and it's important to inform your healthcare provider about any allergies.
What are the storage and disposal instructions for Invoxin-LB 625 Tablet?
Store Invoxin-LB 625 Tablet in its original packaging, tightly sealed. Do not expose it to moisture or direct sunlight. Dispose of any unused medication safely and properly. It should never be consumed by pets, children, or other individuals.
